Abstract
Purpose
The aim of the study was to evaluate the technical success of the procedure and the clinical efficacy of treatment in patients with thromboangiitis obliterans (TAO) (Buerger’s disease) based on a change in the Rutherford classification.
Materials and Methods
A total of 28 consecutive patients (26 males, 2 females, mean age 43.3 ± 5.32 years) underwent endovascular recanalization with a diagnosis of TAO, between April 2015 and July 2018. After unsuccessful attempts using the antegrade approach, retrograde approaches were used in 8 patients under ultrasound guidance. Clinical follow-up was routinely performed at 1-month, 3-month, 6-month, and 1-year intervals.
Results
A total of 28 TAO patients underwent 40 procedures in 32 limbs. Technical success was achieved in 28 of the 32 limbs (87.5%). In total, 45 of 59 (76.2%) below the knee arteries were treated successfully. One major amputation was performed, providing a 96.8% rate for limb salvage both at 12 and 24 months. Amputation-free survival estimated by Kaplan–Meier analysis was 84% at 12 and 24 months. Primary patency rates at 12, 24, and 36 months were 84%, 78%, and 75%, respectively. Secondary patency rates were 87.5% both at 12 and 24 months.
Conclusion
Endovascular treatment is a technically feasible and potentially effective treatment modality for Buerger’s disease. Combined antegrade and retrograde interventions in TAO patients may improve technical success and clinical recovery, especially in cases where the antegrade approach has failed.
Similar content being viewed by others
References
Olin JW. Thromboangiitis obliterans (Buerger’s disease). N Engl J Med. 2000;343:864–9.
Shionoya S. Diagnostic criteria of Buerger’s disease. Int J Cardiol. 1998;66(suppl 1):S243–5.
Piazza G, Creager MA. Thromboangiitis obliterans. Circulation. 2010;121:1858–61.
Arkkila PE. Thromboangiitis obliterans (Buerger’s disease). Orphanet J Rare Dis. 2006;1:14.
Puéchal X, Fiessinger JN. Thromboangiitis obliterans or Buerger’s disease: challenge for the rheumatologist. Rheumatology. 2007;46:192–9.
Suzuki S, Mine H, Umehara I, Yoshida T, Okada Y. Buerger’s disease (thromboangiitis obliterans): an analysis of the arteriograms of 119 cases. Clin Radiol. 1982;33:235–40.
Papa MZ, Rabi I, Adar R. A point scoring system for the clinical diagnosis of Buerger’s disease. Eur J Vasc Endovasc Surg. 1996;11:335–59.
Fujii Y, Soga J, Nakamura S, et al. Classification of corkscrew collaterals in thromboangiitis obliterans (Buerger’s disease): relationship between corkscrew type and prevalence of ischemic ulcers. Circ J. 2010;74(8):1684–8.
Olin JW, Young JR, Graor RA, Ruschhaupt WF, Bartholomew JR. The changing clinical spectrum of thromboangiitis obliterans (Buerger’s disease). Circulation. 1990;82:IV3-8.
Mills JL. Buerger’s disease in the 21st century: diagnosis, clinical features, and therapy. Semin Vasc Surg. 2003;16:179–89.
Neufang A, Vargas-Gomez C, Ewald P, Vitolianos N, Coskun T, Abu-Salim N, et al. Very distal vein bypass in patients with thromboangiitis obliterans. Vasa. 2017;46:304–9.
Graziani L, Morelli L, Parini F, Franceschini L, Spano P, Calza S, et al. Clinical outcome after extended endovascular recanalization in Buerger’s disease in 20 consecutive cases. Ann Vasc Surg. 2012;26:387–95.
Bozkurt AK, Cengiz K, Arslan C, et al. A stable prostacyclin analogue (iloprost) in the treatment of Buerger’s disease: a prospective analysis of 150 patients. Ann Thorac Cardiovasc Surg. 2013;19:120–5.
Fazeli B, Rezaee S. A review on thromboangiitis obliterans pathophysiology: thrombosis and angiitis, which is to blame? Vascular. 2011;19:141–53.
Kröger K. Buerger’s disease: what has the last decade taught us? Eur J Intern Med. 2006;17:227–34.
Rivera-Chavarría IJ, Brenes-Gutiérrez JD. Thromboangiitis obliterans (Buerger’s disease). Ann Med Surg (Lond). 2016;7:79–82.
Seebald J, Gritters L. Thromboangiitis obliterans (Buerger disease). Radiol Case Rep. 2015;10:9–11.
Hemsinli D, Altun G, Kaplan ST, et al. Hyperbaric oxygen treatment in thromboangiitis obliterans: a retrospective clinical audit. Diving Hyperb Med. 2018;48(1):31–5.
Talwar S, Jain S, Porwal R, et al. Pedicled omental transfer for limb salvage in Buerger’s disease. Int J Cardiol. 2000;72(2):127–32.
Bozkurt A, Köksal C, Demirbas M, Erdogan A, Rahman A, Demirkiliç U, et al. A randomized trial of intravenous iloprost (a stable prostacyclin analogue) versus lumbar sympathectomy in the managment of Buerguer’s disease. Int Angiol. 2006;25:162–8.
Guo J, Guo L, Cui S, et al. Autologous bone marrow-derived mononuclear cell therapy in Chinese patients with critical limb ischemia due to thromboangiitis obliterans: 10-year results. Stem Cell Res Ther. 2018;9(1):43.
Bozkurt AK, Beşirli K, Köksal C. Surgical treatment of Buerger’s disease. Vascular. 2004;12(3):192–7.
Kim DH, Ko YG, Ahn CM, et al. Immediate and late outcomes of endovascular therapy for lower extremity arteries in Buerger disease. J Vasc Surg. 2018;67(6):1769–77.
Dargon P, Landry G. Buerger’s disease. Ann Vasc Surg. 2012;26:871–80.
Lee CY, Choi K, Kwon H, et al. Outcomes of endovascular treatment versus bypass surgery for critical limb ischemia in patients with thromboangiitis obliterans. PLoS ONE. 2018;13(10):1–10.
Kawarada O, Kume T, Ayabe S, et al. Endovascular therapy outcomes and intravascular ultrasound findings in thromboangiitis obliterans (Buerger’s disease). J Endovasc Ther. 2017;24(4):504–15.
Modaghegh MS, Hafezi S. Endovascular treatment of thromboangiitis obliterans (Buerger’s disease). Vasc Endovasc Surg. 2018;52(2):124–30.
Becker GJ, Katzen BT, Dake MD. Noncoronary angioplasty. Radiology. 1989;170:921–40.
Bosiers M, Hart JP, Deloose K, Verbist J, Peeters P. Endovascular therapy as the primary approach for limb salvage in patients with critical limb ischemia: experience with 443 infrapopliteal procedures. Vascular. 2006;14(2):63–9.
Papavassiliou VG, Walker SR, Bolia A, Fishwick G, London N. Techniques for the endovascular management of complications following lower limb percutaneous transluminal angioplasty. Eur J Vasc Endovasc Surg. 2003;25(2):125–30.
Pernès JM, Auguste M, Borie H, et al. Infrapopliteal arterial recanalization: a true advance for limb salvage in diabetics. Diagn Interv Imaging. 2015;96(5):423–34.
El-Sayed H, Bennett ME, Loh TM, Davies MG. Retrograde Pedal access and endovascular revascularization: a safe and effective technique for high-risk patients with complex tibial vessel disease. Ann Vasc Surg. 2016;31:91–8.
Montero-Baker M, Schmidt A, Braunlich S, et al. Retrograde approach for complex popliteal and tibioperoneal occlusions. J Endovasc Ther. 2008;15:594–604.
Rogers RK, Dattilo PB, Garcia JA, et al. Retrograde approach to recanalization of complex tibial disease. Catheter Cardiovasc Interv. 2011;77:915–25.
Kilickesmez O, Oguzkurt L. Mechanical thrombectomy with Rotarex system in Buerger’s disease. J Clin Imaging Sci. 2015;5:14.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The author declares that he has no conflict of interest.
Ethical Approval
The ethical committee approval is not required since the study is retrospective.
Informed Consent
Informed consent was obtained from all participants.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Firat, A., Igus, B. Endovascular Recanalization of Thromboangiitis Obliterans (Buerger’s Disease) in Twenty-Eight Consecutive Patients and Combined Antegrade–Retrograde Intervention in Eight Patients. Cardiovasc Intervent Radiol 42, 820–828 (2019). https://doi.org/10.1007/s00270-019-02193-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00270-019-02193-x